| Signs and symptoms [n (%)] |
|
| Renal colic/Lumbar and/or flank pain [n (%)] |
27 (90) |
| Macroscopic hematuria [n (%)] |
19 (82.6) |
| Créatinine clearance* [median (IQR)] |
78.0 [45.6, 98.0] |
| Creatinine clearance* <60 mL/min [n (%)] |
9 (34.6) |
| Stone size (mm) [median (IQR)] |
5.5 [3.9, 9.3] |
| Stone composition percentage [median (IQR)] |
|
| ATV |
89.0 [59.0, 95.0] |
| Proteins |
7.5 [3.0, 10.0] |
| Calcium oxalate |
0 [0; 8] |
| Calcium phosphate |
0 [0, 0] |
| Stone location [n (%)] |
|
| Pyelic |
6 (33.3) |
| Ureteral |
11 (61.1) |
| Bladder |
1 (5.6) |
| Ureteral dilatation [n (%)] |
13 (54.2) |
| Bilateral urolithiasis [n (%)] |
4 (14.3) |
| Treatment [n (%)] |
|
| Medical |
9 (31) |
| Lithotripsy |
2 (6.9) |
| Urologic surgery |
13 (44.8) |
| ATV discontinuation [n (%)] |
24 (82.8) |
| Recurrence of urolithiasis [n (%)] |
3 (10.7) |
| Créatinine clearance* 6–12 months after ATV-urolithiasis (mL/min) [median (IQR)] |
84.5 [69.4, 96.8] |
